(28/04/2024)vs
ΟΜΙΛΟΣ ΕΠΙΧΕΙΡΗΣΕΩΝ ΣΑΡΑΚΑΚΗ | 32 | 14 | 3 / 837.5% | 4 / 1040% | 1 / 250% | 5 / 1241.7% | | 1 | 1 | 2 | 3 | 4 | 0 | 0 | 1 | 8 |
(21/04/2024)vs
LP CLINIC | 30 | 5 | 0 / 00% | 1 / 333.3% | 1 / 1010% | 2 / 1315.4% | | 1 | 1 | 0 | 1 | 2 | 0 | 0 | 3 | -6 |
(20/03/2024)vs
ΑΣΤΡΟΝ ΧΗΜΙΚΑ | 40 | 10 | 1 / 425% | 3 / 837.5% | 1 / 714.3% | 4 / 1526.7% | | 1 | 9 | 3 | 12 | 0 | 0 | 0 | 3 | 5 |
(12/03/2024)vs
ΕΛ.ΣΤΑΤ. | 36 | 12 | 4 / 4100% | 1 / 714.3% | 2 / 922.2% | 3 / 1618.8% | | 1 | 5 | 3 | 8 | 6 | 0 | 0 | 1 | 12 |
(10/03/2024)vs
ΔΗΜΟΣ ΚΗΦΙΣΙΑΣ | 38 | 15 | 4 / 757.1% | 1 / 714.3% | 3 / 1030% | 4 / 1723.5% | | 4 | 4 | 0 | 4 | 1 | 1 | 0 | 0 | 5 |
(03/03/2024)vs
EUROXX | 40 | 28 | 3 / 742.9% | 5 / 1050% | 5 / 1050% | 10 / 2050% | | 2 | 13 | 1 | 14 | 3 | 2 | 0 | 1 | 32 |
(25/02/2024)vs
ΟΜΙΛΟΣ ΕΠΙΧΕΙΡΗΣΕΩΝ ΣΑΡΑΚΑΚΗ | 38 | 7 | 1 / 250% | 3 / 560% | 0 / 100% | 3 / 1520% | | 0 | 7 | 1 | 8 | 0 | 0 | 0 | 2 | 0 |
(18/02/2024)vs
ΑΡΚΑΔΕΣ ΠΕΡΙΣΤΕΡΙΟΥ | 38 | 21 | 7 / 977.8% | 1 / 520% | 4 / 1040% | 5 / 1533.3% | | 2 | 9 | 1 | 10 | 1 | 3 | 0 | 4 | 19 |
(04/02/2024)vs
ΑΜΥΝΤΑΣ BC | 24 | 0 | 0 / 00% | 0 / 30% | 0 / 40% | 0 / 70% | | 2 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | -6 |
(30/01/2024)vs
Σ.Υ.Β. | 31 | 21 | 9 / 1090% | 3 / 475% | 2 / 1020% | 5 / 1435.7% | | 3 | 7 | 1 | 8 | 2 | 0 | 1 | 3 | 19 |
(14/01/2024)vs
LP CLINIC | 00 | 12 | 0 / 00% | 3 / 837.5% | 2 / 633.3% | 5 / 1435.7% | | 3 | 4 | 3 | 7 | 1 | 1 | 0 | 1 | 11 |
(17/12/2023)vs
ΔΗΜΟΣ ΚΗΦΙΣΙΑΣ | 39 | 11 | 3 / 475% | 1 / 616.7% | 2 / 1118.2% | 3 / 1717.6% | | 0 | 6 | 0 | 6 | 2 | 2 | 0 | 3 | 3 |
(10/12/2023)vs
EUROXX | 00 | 19 | 2 / 450% | 4 / 944.4% | 3 / 1030% | 7 / 1936.8% | | 2 | 6 | 2 | 8 | 2 | 2 | 0 | 0 | 17 |
(03/12/2023)vs
ΑΡΚΑΔΕΣ ΠΕΡΙΣΤΕΡΙΟΥ | 30 | 14 | 6 / 6100% | 1 / 250% | 2 / 540% | 3 / 742.9% | | 1 | 3 | 0 | 3 | 3 | 1 | 0 | 2 | 15 |
(26/11/2023)vs
ΑΣΤΡΟΝ ΧΗΜΙΚΑ | 16 | 6 | 1 / 250% | 1 / 520% | 1 / 250% | 2 / 728.6% | | 0 | 4 | 0 | 4 | 1 | 0 | 0 | 1 | 4 |
(19/11/2023)vs
ΟΜΙΛΟΣ ΕΠΙΧΕΙΡΗΣΕΩΝ ΣΑΡΑΚΑΚΗ | 00 | 18 | 4 / 580% | 4 / 850% | 2 / 633.3% | 6 / 1442.9% | | 1 | 4 | 2 | 6 | 1 | 0 | 0 | 1 | 15 |
(12/11/2023)vs
ΑΜΥΝΤΑΣ BC | 27 | 13 | 0 / 10% | 2 / 450% | 3 / 650% | 5 / 1050% | | 0 | 5 | 0 | 5 | 0 | 0 | 0 | 0 | 12 |
(05/11/2023)vs
BST / NIGICO | 36 | 22 | 1 / 333.3% | 3 / 560% | 5 / 955.6% | 8 / 1457.1% | | 2 | 11 | 0 | 11 | 1 | 0 | 0 | 2 | 24 |
(22/10/2023)vs
LP CLINIC | 34 | 15 | 1 / 250% | 4 / 580% | 2 / 922.2% | 6 / 1442.9% | | 2 | 3 | 2 | 5 | 2 | 1 | 0 | 2 | 12 |
(15/10/2023)vs
ANIMAL PRINTERS | 23 | 12 | 1 / 250% | 1 / 714.3% | 3 / 560% | 4 / 1233.3% | | 1 | 6 | 1 | 7 | 2 | 1 | 1 | 1 | 13 |
| ΣΥΝΟΛΙΚΑ |
552 |
275 |
51 / 8063.8% |
46 / 12138.0% |
44 / 15129.1% |
90 / 27233.1% |
|
29 |
109 |
22 |
131 |
35 |
14 |
2 |
32 |
214 |
| ΜΕΣΟΙ ΟΡΟΙ |
27.6 |
13.8 |
2.6 / 463.8% |
2.3 / 6.038.0% |
2.2 / 7.629.1% |
4.5 / 13.633.1% |
|
1.4 |
5.4 |
1.1 |
6.6 |
1.8 |
0.7 |
0.1 |
1.6 |
10.7 |